A landmark Australian trial will test olfactory cell transplantation combined with intensive rehab to restore function in chronic …
A landmark Australian trial will test olfactory cell transplantation combined with intensive rehab to restore function in chronic …
With fresh capital and a new pipeline strategy, Replicor aims to tackle chronic viral infections and rare liver …
ExoGene’s novel delivery platform earns RMAT status for its lead candidate EXG-401, targeting neuroinflammation and motor neuron survival …
Personalized mRNA cancer vaccine combined with Keytruda delivers sustained recurrence-free survival in high-risk melanoma patients, reinforcing immunotherapy’s future.